语言版本

Time of issue:2021-09-02 16:56:33
搜索
Search
/
/
R&D Product
All categories

 

Name CAS # Therapeutic Category TP Status
Rifabutin 72559-06-9 Antimycobacterials PV completed
Ibrutinib 936563-96-1 Antineoplastics PV completed
Rupatadine fumarate 182349-12-8 Antiallergics PV completed
Enzalutamide 915087-33-1 Antineoplastics PV completed
Finerenone 1050477-31-0 Antineoplastics PV completed
Pacritinib 937272-79-2 Antineoplastics Pilot
Calcitriol 169900-32-7 Metabolic Bone Disease Agents   Pilot
Upadacitinib 1310726-60-3 Antineoplastics Pilot
Perfluorohexyloctane 133331-77-8 Ophthalmic Agents   Pilot
Darolutamide 1297538-32-9 Antineoplastics Pilot
Nalfurafine Hydrochloride 152658-17-8 Dermatological Agents   Development
Mirogabalin 1138245-13-2 Analgesics   Development
Eravacycline 1207283-85-9 Antibacterials   Development
Elacestrant hydrochloride 1349723-93-8 Antineoplastics   Development

 

*Disclaimer: All products currently covered by valid patents are offered for R&D use only, any patent infringement and resulting liability is solely at buyer risk.

RELATED WEBSITES

友情链接

Time of issue:2020-07-27 00:00:00
Online customer service
Customer service hotline
+86-023-67886928 +86-023-67886928
Service time:
8:30 - 17:30
Customer service group:
在线客服

地址版权

Time of issue:2019-05-10 00:00:00

© 2021 Chongqing Huapont Pharmaceutical Co., Ltd. All Rights Reserved.  渝ICP备2021007919号  1渝公网安备50011702500758号  Powered by:www.300.cn

地址版权手机

Time of issue:2019-05-10 00:00:00

© 2021 Chongqing Huapont Pharmaceutical Co., Ltd.

渝ICP备2021007919号  Powered by:www.300.cn

1渝公网安备50011702500758号